SCIENTURE HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
SCIENTURE HOLDINGS, INC. (SCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 0.25% for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-25.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2021-10-25
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2021-03-31 was 0.25%, a 99.89% decline year-over-year.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2020-03-31 was 226.00%.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2020 was 0.25%, a 99.90% decline from fiscal 2019.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2019 was 250.00%, a 5.66% decline from fiscal 2018.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2018 was 265.00%, a 32.50% increase from fiscal 2017.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2017 was 200.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|---|
| 2021-09-30 | 0.25% 10-Q · filed 2021-10-25 | |||
| 2021-06-30 | 0.25% 10-Q · filed 2021-07-26 | |||
| 2021-03-31 | 0.25% 10-Q · filed 2021-04-26 | |||
| 2020-12-31 | 0.25% 10-K · filed 2021-03-29 | |||
| 2020-09-30 | 236.00% 10-Q · filed 2020-10-26 | |||
| 2020-06-30 | 236.00% 10-Q · filed 2020-07-27 | |||
| 2020-03-31 | 226.00% 10-Q · filed 2020-05-04 | |||
| 2019-12-31 | 250.00% 10-K · filed 2020-03-30 | |||
| 2019-09-30 | 250.00% 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | 250.00% 10-Q · filed 2019-07-26 | |||
| 2018-12-31 | 265.00% 10-K · filed 2020-03-30 | |||
| 2017-12-31 | 200.00% 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |